- Recent Funding
- Investors
- Jazz Venture Partners
Jazz Venture Partners portfolio
Jazz Venture Partners has 5 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in San Francisco, US, founded in 2015. Its most recent investment on record is Transcripta Bio's $24M Series A round in July 2026, alongside Omnimed Capital, Mayo Clinic and BlueYard Capital. By category, its portfolio leans toward Health and bio (3) and Data and analytics (2). It has co-invested with True Ventures, Level Ventures and FPV Ventures, most often True Ventures (2 rounds).
About Jazz Venture Partners
What Jazz Venture Partners invests in
- Health and bio · 3 · 60%
- Data and analytics · 2 · 40%
- Education · 2 · 40%
- Voice and audio AI · 1 · 20%
- Legal and compliance · 1 · 20%
- Robotics and hardware · 1 · 20%
- Insurance · 1 · 20%
Jazz Venture Partners recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $24M | Omnimed Capital (lead), Mayo Clinic (lead), BlueYard Capital | ||
| Series A · $45M | Scott Banister, Long Journey Ventures, Ryan Hoover +6 | ||
| Series A · $23M | Navigate Ventures, Markd (lead), Verstra Ventures +2 | ||
| Series B+ · $55M | Kinnevik, Level Ventures, True Ventures +5 | ||
| Series B+ · $68M | Level Ventures, Lux Capital, Hummingbird VC +6 | ||
| Series B+ · $50M | McKesson Ventures, Trajectory Ventures, Lux Capital (lead) +6 |
How Jazz Venture Partners invests
Jazz Venture Partners portfolio companies
TTranscripta Bio$24MSeries A · Jul 2026
JJustPoint$45MSeries A · Jan 2025
PPinpoint Predictive$23MSeries A · Oct 2024
EEnveda$55MSeries B+ · Jun 2024
AAllStripes$50MSeries B+ · Aug 2021
| Company | Round with Jazz Venture Partners | Total raised | Latest raise |
|---|---|---|---|
Voice and audio AI |
Series A · $24M | $24M | Jul 23, 2026 Series A |
Legal and compliance |
Series A · $45M | $53M | Mar 11, 2026 Seed |
Insurance |
Series A · $23M | $23M | Oct 9, 2024 Series A |
Health and bio |
Series B+ · $55M | $714M | Sep 23, 2026 Series B+ |
Health and bio |
Series B+ · $50M | $67M | Aug 24, 2021 Series B+ |
Most frequent co-investors
TTrue Ventures2 shared rounds · last Jun 14, 2024
LLevel Ventures2 shared rounds · last Jun 14, 2024
FFPV Ventures2 shared rounds · last Jun 14, 2024
LLux Capital2 shared rounds · last Dec 21, 2022
MMayo Clinic1 shared round · last Jul 23, 2026
BBlueYard Capital1 shared round · last Jul 23, 2026
- OOmnimed Capital1 shared round · last Jul 23, 2026
SSignalFire1 shared round · last Jan 1, 2025
WWeekend Fund1 shared round · last Jan 1, 2025
IInterplay1 shared round · last Jan 1, 2025
WWormhole Capital1 shared round · last Jan 1, 2025
LLong Journey Ventures1 shared round · last Jan 1, 2025
Similar investors
GGenoa Ventures5 companies · 4 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
CCatalyst Health Ventures5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 6 rounds on Recent Funding that name Jazz Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Jazz Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/jazz-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.